Interventional Glaucoma: The Convergence of Surgical Innovation and Therapeutic Hope

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

In this podcast, Philadelphia cornea and glaucoma surgeon Brian Shafer, MD, discusses the procedures and processes involved in interventional glaucoma, which offers earlier options such as laser, drug-releasing implants, MIGS, and MIBS, with less reliance on topical medications in appropriate patients.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Describe the various surgical techniques for glaucoma management based on their mechanisms, safety profiles, and clinical outcomes
• Apply patient selection criteria to determine the appropriate minimally invasive glaucoma surgery (MIGS) and procedural pharmaceutical approaches for individuals with varying glaucoma severity

Acknowledgment of Educational Grant Support

This activity is supported by educational grants from AbbVie Inc., Carl Zeiss Meditec, Inc, Glaukos Corporation, Sight Sciences, Inc., and Topcon Healthcare, Inc.

Chair:

Brian Shafer, MD

Shafer Vision Institute, Founder and CEO
Adjunct Assistant Professor of Ophthalmology, University of Pennsylvania
Adjunct Assistant Professor of Ophthalmology, Temple University
Clinical Instructor, Wills Eye Hospital

Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AbbVie, Alcon, Bausch + Lomb, CorneaGen, Glaukos, Harrow Pharmaceuticals, RxSight

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

This podcast, including the narration, was developed by PER® editorial staff based on a live activity developed with this faculty. The narration was voiced by a PER staff member or an AI tool.

Release Date

February 27, 2026

Expiration Date

February 27, 2027

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.